You are here: Industry Insights > Johnson & Johnson

News List

Johnson & Johnson's Covid-19 vaccine holds up in US durability study FirstWordPharma
January 07, 2022
Findings were unveiled Thursday from the largest US study to date on the durability of COVID-19 vaccines, with Johnson & Johnson's jab producing a robust result in terms...
Health Canada approves Johnson & Johnson’s single-dose Covid-19 vaccine Pharmaceutical-Business-Review
November 26, 2021
Health Canada has granted full approval to Janssen Pharmaceutical Companies of Johnson & Johnson’s single-dose Covid-19 vaccine for the disease prevention in people aged 18 years and above.
Johnson & Johnson COVID-19 Vaccine Fully Approved by Health Canada to Prevent COVID-19 in Individuals 18 years and Older AmericanPharmaceuticalReview
November 25, 2021
The Janssen Pharmaceutical Companies of Johnson & Johnson announced that Health Canada has approved its single-shot COVID-19 vaccine to prevent COVID-19 in individuals 18 years of age and older.
Johnson & Johnson COVID-19 vaccine named one of Time's Best Inventions of 2021 WorldPharmaNews
November 15, 2021
The editors of Time announced that the Johnson & Johnson COVID-19 vaccine has been selected as one of Time's Best Inventions of 2021.
Statement on Boosting with the Johnson & Johnson COVID-19 Vaccine drugs
August 20, 2021
We are engaging with the U.S. FDA, CDC and other health authorities and will share new data shortly regarding boosting with the Johnson & Johnson COVID-19 vaccine.
BioMed X, Janssen Begin Autoimmunity and Drug Delivery Research contractpharma
August 05, 2021
New research groups, PTA and TMI, aim to combat chronic inflammatory diseases and develop oral delivery of macromolar therapeutics.
Biden Offers COVID-19 Vaccines to Migrants in Custody Along Mexican Border drugs
August 05, 2021
COVID-19 vaccines will be offered to migrants in U.S. custody at the Mexican border, federal government officials said Tuesday.
Johnson & Johnson Statement on U.S. FDA Approval of Shelf Life Extension for Company’s COVID-19 Vaccine drugs
July 29, 2021
We are pleased to confirm the U.S. Food & Drug Administration (FDA) has extended the shelf life for the Johnson & Johnson single-shot COVID-19 vaccine to six months. The decision is based on data from ongoing stability assessment studies.
One Dose of J.&J. Vaccine Is Ineffective Against Delta, Study Suggests firstwordpharma
July 21, 2021
According to results from a laboratory study posted online on Tuesday, Johnson & Johnson's COVID-19 vaccine is much less effective against the Delta and Lambda variants than against the original virus, The New York Times reported.
Johnson & Johnson Innovation announces extension of innovation partnering office at Monash University in collaboration with Victorian State Government to accelerate the life-sciences hub prnasia
July 15, 2021
Johnson & Johnson Innovation announced today the extension of the Johnson & Johnson Innovation Partnering Office at Monash University's Clayton Campus in Melbourne (JJIPO@Monash) in collaboration with the Victorian State Government.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 15 16 Next page